Literature DB >> 21718821

The use of veritas collagen matrix to reconstruct the posterior chest wall after costovertebrectomy.

Gaetano Rocco1, Luca Serra, Flavio Fazioli, Stefano Mori, Farrokh Mehrabi-Kermani, Agostino Capasso, Nicola Martucci, Antonello La Rocca, Gaetano Apice.   

Abstract

Among the new materials introduced for chest wall reconstruction, the use of collagen matrix is gaining increasing favor for its biomechanical properties. We describe the reconstruction of the chest wall with Veritas (Synovis, St Paul, MN) collagen matrix of a posterior chest wall defect after costovertebrectomy for Ewing's sarcoma. En bloc resection was performed, including partial D7 through D9 vertebrectomy along with the posterolateral segments of corresponding ribs. The collagen matrix patch was sutured to the spine stabilizer and the surrounding rib segments and was covered by previously raised latissimus dorsi and trapezius muscle flaps. Excellent stabilization was obtained.
Copyright © 2011 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21718821     DOI: 10.1016/j.athoracsur.2011.02.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Video-assisted paraspinal approach for the stabilization of the complex spine.

Authors:  Gaetano Rocco; Luca Serra; Farrokh Mehrabi-Kermani; Sergio Setola
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-12

2.  Experience with titanium devices for rib fixation and coverage of chest wall defects.

Authors:  Andrea Billè; Lawrence Okiror; Wolfram Karenovics; Tom Routledge
Journal:  Interact Cardiovasc Thorac Surg       Date:  2012-07-19

Review 3.  Primary lung tumors invading the chest wall.

Authors:  Pier Luigi Filosso; Alberto Sandri; Francesco Guerrera; Paolo Solidoro; Giulia Bora; Paraskevas Lyberis; Enrico Ruffini; Alberto Oliaro
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.